FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2175747788> ?p ?o ?g. }

• W2175747788 endingPage "33216" @default.
• W2175747788 startingPage "33206" @default.
• W2175747788 abstract "We investigated the efficacy of targeting the PIM kinase pathway in Philadelphia chromosome-positive (Ph+) leukemias. We provide evidence that inhibition of PIM, with the pan-PIM inhibitor SGI-1776, results in suppression of classic PIM effectors and also elements of the mTOR pathway, suggesting interplay between PIM and mTOR signals. Our data demonstrate that PIM inhibition enhances the effects of imatinib mesylate on Ph+ leukemia cells. We also found that PIM inhibition results in suppression of leukemic cell proliferation and induction of apoptosis of Ph+ leukemia cells, including those resistant to imatinib mesylate. Importantly, inhibition of PIM results in enhanced suppression of primary leukemic progenitors from patients with CML. Altogether these findings suggest that pharmacological PIM targeting may provide a unique therapeutic approach for the treatment of Ph+ leukemias." @default.
• W2175747788 created "2016-06-24" @default.
• W2175747788 creator A5020590699 @default.
• W2175747788 creator A5025780450 @default.
• W2175747788 creator A5035824072 @default.
• W2175747788 creator A5051335860 @default.
• W2175747788 creator A5061285204 @default.
• W2175747788 creator A5077679072 @default.
• W2175747788 creator A5088523514 @default.
• W2175747788 creator A5090728420 @default.
• W2175747788 date "2015-09-07" @default.
• W2175747788 modified "2023-10-17" @default.
• W2175747788 title "Pre-clinical evidence of PIM kinase inhibitor activity in BCR-ABL1 unmutated and mutated Philadelphia chromosome-positive (Ph+) leukemias" @default.
• W2175747788 cites W1490240498 @default.
• W2175747788 cites W1857478378 @default.
• W2175747788 cites W1966370450 @default.
• W2175747788 cites W1970701525 @default.
• W2175747788 cites W1987380844 @default.
• W2175747788 cites W1993675254 @default.
• W2175747788 cites W2014457555 @default.
• W2175747788 cites W2016809033 @default.
• W2175747788 cites W2017366419 @default.
• W2175747788 cites W2032320747 @default.
• W2175747788 cites W2032324197 @default.
• W2175747788 cites W2033341978 @default.
• W2175747788 cites W2052117124 @default.
• W2175747788 cites W2061562309 @default.
• W2175747788 cites W2068605060 @default.
• W2175747788 cites W2071281521 @default.
• W2175747788 cites W2075586116 @default.
• W2175747788 cites W2079410007 @default.
• W2175747788 cites W2085332855 @default.
• W2175747788 cites W2087815009 @default.
• W2175747788 cites W2089130049 @default.
• W2175747788 cites W2089655089 @default.
• W2175747788 cites W2098629192 @default.
• W2175747788 cites W2100136475 @default.
• W2175747788 cites W2103935957 @default.
• W2175747788 cites W2110648386 @default.
• W2175747788 cites W2130197839 @default.
• W2175747788 cites W2140472738 @default.
• W2175747788 cites W2147109509 @default.
• W2175747788 cites W2157499839 @default.
• W2175747788 cites W2158026056 @default.
• W2175747788 cites W2158467060 @default.
• W2175747788 cites W2160075057 @default.
• W2175747788 cites W2160848637 @default.
• W2175747788 cites W2167177526 @default.
• W2175747788 cites W2171218023 @default.
• W2175747788 cites W2297290849 @default.
• W2175747788 cites W2916183363 @default.
• W2175747788 cites W4246003869 @default.
• W2175747788 doi "https://doi.org/10.18632/oncotarget.5091" @default.
• W2175747788 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4741759" @default.
• W2175747788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26375673" @default.
• W2175747788 hasPublicationYear "2015" @default.
• W2175747788 type Work @default.
• W2175747788 sameAs 2175747788 @default.
• W2175747788 citedByCount "11" @default.
• W2175747788 countsByYear W21757477882016 @default.
• W2175747788 countsByYear W21757477882018 @default.
• W2175747788 countsByYear W21757477882019 @default.
• W2175747788 countsByYear W21757477882021 @default.
• W2175747788 countsByYear W21757477882023 @default.
• W2175747788 crossrefType "journal-article" @default.
• W2175747788 hasAuthorship W2175747788A5020590699 @default.
• W2175747788 hasAuthorship W2175747788A5025780450 @default.
• W2175747788 hasAuthorship W2175747788A5035824072 @default.
• W2175747788 hasAuthorship W2175747788A5051335860 @default.
• W2175747788 hasAuthorship W2175747788A5061285204 @default.
• W2175747788 hasAuthorship W2175747788A5077679072 @default.
• W2175747788 hasAuthorship W2175747788A5088523514 @default.
• W2175747788 hasAuthorship W2175747788A5090728420 @default.
• W2175747788 hasBestOaLocation W21757477881 @default.
• W2175747788 hasConcept C104317684 @default.
• W2175747788 hasConcept C126322002 @default.
• W2175747788 hasConcept C138626823 @default.
• W2175747788 hasConcept C170493617 @default.
• W2175747788 hasConcept C190283241 @default.
• W2175747788 hasConcept C203014093 @default.
• W2175747788 hasConcept C2777583451 @default.
• W2175747788 hasConcept C2778461978 @default.
• W2175747788 hasConcept C2778729363 @default.
• W2175747788 hasConcept C2778904597 @default.
• W2175747788 hasConcept C3019892230 @default.
• W2175747788 hasConcept C43907098 @default.
• W2175747788 hasConcept C502942594 @default.
• W2175747788 hasConcept C54355233 @default.
• W2175747788 hasConcept C71924100 @default.
• W2175747788 hasConcept C86554907 @default.
• W2175747788 hasConcept C86803240 @default.
• W2175747788 hasConceptScore W2175747788C104317684 @default.
• W2175747788 hasConceptScore W2175747788C126322002 @default.
• W2175747788 hasConceptScore W2175747788C138626823 @default.
• W2175747788 hasConceptScore W2175747788C170493617 @default.
• W2175747788 hasConceptScore W2175747788C190283241 @default.
• W2175747788 hasConceptScore W2175747788C203014093 @default.
• W2175747788 hasConceptScore W2175747788C2777583451 @default.

• next